Hepatic encephalopathy: effects of liver failure on brain function. (Q38154754)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149188%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Hepatic encephalopathy: effects of liver failure on brain function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149188%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

main subject

hepatic encephalopathy

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149188%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Vicente Felipo

series ordinal

1

1 reference

29 August 2017

language of work or name

English

0 references

publication date

23 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149188%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Neuroscience

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149188%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149188%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149188%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

851-858

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149188%20AND%20SRC:MED&resulttype=core&format=json

In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009.

28 February 2020

cites work

1 reference

New assessment of hepatic encephalopathy

21 January 2018

1 reference

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

21 January 2018

1 reference

Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

21 January 2018

1 reference

Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy

21 January 2018

1 reference

Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis.

21 January 2018

1 reference

Motor-evoked potentials in awake rats are a valid method of assessing hepatic encephalopathy and of studying its pathogenesis.

21 January 2018

1 reference

Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure

21 January 2018

1 reference

Brain region-selective mechanisms contribute to the progression of cerebral alterations in acute liver failure in rats.

21 January 2018

1 reference

Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline

21 January 2018

1 reference

Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.

21 January 2018

1 reference

Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity

21 January 2018

1 reference

Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts.

21 January 2018

1 reference

Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy

21 January 2018

1 reference

Hyperammonemia increases sensitivity to LPS.

21 January 2018

1 reference

Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?

21 January 2018

1 reference

The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation.

21 January 2018

1 reference

Mini-asterixis in hepatic encephalopathy induced by pathologic thalamo-motor-cortical coupling.

21 January 2018

1 reference

Altered brain functional connectivity in patients with cirrhosis and minimal hepatic encephalopathy: a functional MR imaging study.

21 January 2018

1 reference

Structural and functional abnormalities of default mode network in minimal hepatic encephalopathy: a study combining DTI and fMRI.

21 January 2018

1 reference

Effects of hyperammonemia and liver failure on glutamatergic neurotransmission

21 January 2018

1 reference

Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy

21 January 2018

1 reference

Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex

21 January 2018

1 reference

Motor activity is modulated via different neuronal circuits in rats with chronic liver failure than in normal rats.

21 January 2018

1 reference

Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra

21 January 2018

1 reference

p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts.

21 January 2018

1 reference

Chronic liver failure in rats impairs glutamatergic synaptic transmission and long-term potentiation in hippocampus and learning ability

21 January 2018

1 reference

Region selective alterations of soluble guanylate cyclase content and modulation in brain of cirrhotic patients.

21 January 2018

1 reference

Chronic hyperammonemia reduces the activity of neuronal nitric oxide synthase in cerebellum by altering its localization and increasing its phosphorylation by calcium-calmodulin kinase II.

21 January 2018

1 reference

Therapeutic hypothermia in the management of acute liver failure.

21 January 2018

1 reference

Rifaximin treatment in hepatic encephalopathy

21 January 2018

1 reference

Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy

21 January 2018

1 reference

A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy

21 January 2018

1 reference

Experimental models of hepatic encephalopathy: ISHEN guidelines.

21 January 2018

1 reference

3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis

21 January 2018

1 reference

Cerebral oedema is not responsible for motor or cognitive deficits in rats with hepatic encephalopathy.

31 March 2020

1 reference

NMDA receptor antagonists prevent acute ammonia toxicity in mice

31 March 2020

1 reference

Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow

31 March 2020

1 reference

IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy

31 March 2020

1 reference

Microglia activation in hepatic encephalopathy in rats and humans

31 March 2020

1 reference

Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy

31 March 2020

1 reference

Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests

31 March 2020

1 reference

Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension

31 March 2020

1 reference

Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension

31 March 2020

1 reference

Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24149188

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24149188